TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 0 | 7 | 27 | -15 | -18 | 26 | 6 |
| P | %wins | 50 | 100 | 100 | 0 | 0 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/20 19:28 | 3/19/20 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kelley Kenneth J | CA | D | P | 749 | 14.23 | 0 | 53 | 23 | 278 | D | |||||||||||||||
8/28/12 18:22 | 8/27/12 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelley Kenneth J | CA | D | P | 114 | 5.70 | 10 | 20 | 15 | 150 | D | -16 | -16 | -52 | -30 | -36 | -6 | -5 | -1 | -1 | 4 | 37 | -3 | -3 | 45 | |
5/16/12 16:11 | 5/14/12 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelley Kenneth J | CA | D | P | 150 | 7.49 | 7 | 20 | 18 | 130 | D | -1 | 13 | -10 | -36 | -42 | -9 | -5 | 0 | 1 | 9 | 17 | -26 | -32 | 7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |